High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv

被引:82
作者
Reynolds, Robert C. [1 ]
Ananthan, Subramaniam [1 ]
Faaleolea, Ellen [2 ]
Hobrath, Judith V. [1 ]
Kwong, Cecil D. [1 ]
Maddox, Clinton [1 ]
Rasmussen, Lynn [1 ]
Sosa, Melinda I. [1 ]
Thammasuvimol, Elizabeth [2 ]
White, E. Lucile [1 ]
Zhang, Wei [1 ]
Secrist, John A., III [1 ]
机构
[1] So Res Inst, Birmingham, AL 35205 USA
[2] So Res Inst, Frederick, MD 21701 USA
关键词
TAACF; Antitubercular; High throughput screening methods; Medicinal chemistry analysis; Designed kinase inhibitor library; CYCLIN-DEPENDENT KINASES; PROTEIN-KINASES; 1,3,4-OXADIAZOLE DERIVATIVES; ANTIMYCOBACTERIAL ACTIVITY; STRUCTURE CLASSIFICATION; ANTITUBERCULAR ACTIVITY; MAP KINASE; AGENTS; POTENT; PHOSPHORYLATION;
D O I
10.1016/j.tube.2011.05.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Kinase targets are being pursued in a variety of diseases beyond cancer, including immune and metabolic as well as viral, parasitic, fungal and bacterial. In particular, there is a relatively recent interest in kinase and ATP-binding targets in Mycobacterium tuberculosis in order to identify inhibitors and potential drugs for essential proteins that are not targeted by current drug regimens. Herein, we report the high throughput screening results for a targeted library of approximately 26,000 compounds that was designed based on current kinase inhibitor scaffolds and known kinase binding sites. The phenotypic data presented herein may form the basis for selecting scaffolds/compounds for further enzymatic screens against specific kinase or other ATP-binding targets in Mycobacterium tuberculosis based on the apparent activity against the whole bacteria in vitro. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:72 / 83
页数:12
相关论文
共 75 条
[1]   High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv [J].
Ananthan, Subramaniam ;
Faaleolea, Ellen R. ;
Goldman, Robert C. ;
Hobrath, Judith V. ;
Kwong, Cecil D. ;
Laughon, Barbara E. ;
Maddry, Joseph A. ;
Mehta, Alka ;
Rasmussen, Lynn ;
Reynolds, Robert C. ;
Secrist, John A., III ;
Shindo, Nice ;
Showe, Dustin N. ;
Sosa, Melinda I. ;
Suling, William J. ;
White, E. Lucile .
TUBERCULOSIS, 2009, 89 (05) :334-353
[2]  
BUKOWSKI L, 1986, POL J PHARMACOL PHAR, V38, P91
[3]   Protein kinases as targets for antiparasitic chemotherapy drugs [J].
Canduri, Fernanda ;
Cardoso Perez, Patricia ;
Caceres, Rafael A. ;
de Azevedo, Walter F., Jr. .
CURRENT DRUG TARGETS, 2007, 8 (03) :389-398
[4]   Synthesis and antiproliferative activity of 3-aryl-2-(1H-benzotriazol-1-yl)acrylonitriles.: Part III [J].
Carta, A ;
Sanna, P ;
Palomba, M ;
Vargiu, L ;
La Colla, M ;
Loddo, R .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2002, 37 (11) :891-900
[5]   Identification of N-(5-tert-Butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea Dihydrochloride (AC220), a Uniquely Potent, Selective, and Efficacious FMS-Like Tyrosine Kinase-3 (FLT3) Inhibitor [J].
Chao, Qi ;
Sprankle, Kelly G. ;
Grotzfeld, Robert M. ;
Lai, Andiliy G. ;
Carter, Todd A. ;
Velasco, Anne Marie ;
Gunawardane, Ruwanthi N. ;
Cramer, Merryl D. ;
Gardner, Michael F. ;
James, Joyce ;
Zarrinkar, Patrick P. ;
Patel, Hitesh K. ;
Bhagwat, Shripad S. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (23) :7808-7816
[6]   A comprehensive update of the sequence and structure classification of kinases [J].
Cheek, S ;
Ginalski, K ;
Zhang, H ;
Grishin, NV .
BMC STRUCTURAL BIOLOGY, 2005, 5
[7]   Sequence and structure classification of kinases [J].
Cheek, S ;
Zhang, H ;
Grishin, NV .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 320 (04) :855-881
[8]   Recent kinase and kinase inhibitor X-ray structures: Mechanisms of inhibition and selectivity insights [J].
Cherry, M ;
Williams, DH .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (06) :663-673
[9]  
Chu W-LA, 2001, Patent No. [US/2001/6307070 B1, 20016307070]
[10]   Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium [J].
Collins, LA ;
Franzblau, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1004-1009